Related Experiment Videos
Serum I-K (immunoconglutinins) in Hodgkin's disease
Biomedicine / [Publiee Pour L'A.A.I.C.I.G.]
|February 28, 1975
Insights
Elevated C
Area of Science:
- Immunology
- Oncology
- Clinical Chemistry
Background:
- Hodgkin's disease is a lymphoproliferative disorder.
- Complement system activation is implicated in various immune responses.
- C'3 fraction and conglutinins are key components of the complement system.
Purpose of the Study:
- To confirm and describe the elevation of the C'3 fraction in Hodgkin's disease patients.
- To investigate the nature of conglutinins in Hodgkin's disease patients.
Main Methods:
- Quantification of C'3 fraction levels in patient serum.
- Comparison of C'3 levels between Hodgkin's disease patients and healthy controls.
- Analysis of conglutinin behavior in patient samples.
Main Results:
- A confirmed increase in the C'3 fraction was observed in 33 Hodgkin's disease patients across various clinical stages.
- C'3 fraction levels were consistently higher in patients compared to 26 normal subjects.
- Conglutinins in Hodgkin's disease patients exhibited characteristics of immunoconglutinins (I-K).
Conclusions:
- Elevated C'3 fraction is a consistent finding in Hodgkin's disease.
- Immunoconglutinins (I-K) may play a role in the immunological profile of Hodgkin's disease.
Abstract:
An increase of C'3 fraction, already observed in Hodgkin's disease has been confirmed, and is here described in a group of 33 patients at various clinical stages of Hodgkin's disease. It is consistently higher than those found in a group of 26 normal subjects. Conglutinins present in Hodgkin's disease patients, as far as their behaviour is concerned, may be considered as immunoconglutinins (I-K).